NCT00274937 · OUTCOME

Protective Effects of Amifostine Assessed Primarily by Sialometry: Weight of Unstimulated Saliva Production in Grams.

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer · Source last updated 2022-10-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: Grams of saliva
Interval / dispersion: Standard Deviation
Time frame: At study enrollment

What was measured

Weight of unstimulated saliva production in grams.

Analysis population: Twenty-nine patients in stratum 2 were evaluated at both study enrollment and at the end of consolidation for the weight of unstimulated saliva production. This outcome measure was only collected for patients in Stratum 2.

Groups in this outcome

Stratum II

AJCC Stage IIb - IV

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Stratum II	29

Reported measurements

At study Enrollment

Values in Grams of saliva · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Stratum II	3.37	4.49	Not reported	Not reported	Not reported

At end of consolidation

Values in Grams of saliva · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Stratum II	2.30	3.90	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
4.49
value
3.37
title
At study Enrollment
categories
measurements
group Id
OG000
spread
3.90
value
2.30
title
At end of consolidation

denoms

counts
group Id
OG000
value
29
units
Participants

description

Weight of unstimulated saliva production in grams.

dispersion Type

Standard Deviation

groups

description
AJCC Stage IIb - IV
id
OG000
title
Stratum II

param Type

MEAN

population Description

Twenty-nine patients in stratum 2 were evaluated at both study enrollment and at the end of consolidation for the weight of unstimulated saliva production. This outcome measure was only collected for patients in Stratum 2.

reporting Status

POSTED

time Frame

At study enrollment

title

Protective Effects of Amifostine Assessed Primarily by Sialometry: Weight of Unstimulated Saliva Production in Grams.

type

SECONDARY

unit Of Measure

Grams of saliva

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice